<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New veterinary bone graft substitute</title><link>/b/veterinary-news/posts/new-veterinary-bone-graft-substitute</link><description> TheraVet S.A., a Belgian company which specialises in the management of osteoarticular diseases in pets, has announced the launch of Biocera-Vet, an injectable bone substitute for use in orthopaedic surgery. 
 The company says that despite the development</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>